Vaxxinity Investor Relations Material
Latest events
Q4 2023
27 Mar, 2024
Corporate Presentation
12 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Vaxxinity Inc
Access all reports
Vaxxinity Inc. is a biotechnology company focused on developing immunotherapies for chronic diseases and infectious conditions. The company specializes in vaccine-based treatments designed to harness the immune system for conditions such as neurodegenerative disorders, cardiovascular diseases, and viral infections. The company is headquartered in Dallas, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
VAXX
Country
🇺🇸 United States